Creatine is a guanidino compound that is synthesised in the body from the amino acids arginine, glycine, and methionine (by the enzymes arginine:glycine amidinotransferase, AGAT, and guanidinoacetate methyltransferase, GAMT) and that is essential for the rapid regeneration of ATP during high-intensity muscle contraction. In resting muscle, creatine is converted to phosphocreatine (PCr) by the creatine kinase (CK) reaction, which uses ATP to phosphorylate creatine. When muscle contracts vigorously and ATP is rapidly consumed, the PCr stores are mobilised to regenerate ATP by the reverse CK reaction, buffering the ATP concentration and allowing high-intensity muscle contraction to continue when the glycolytic and oxidative ATP production systems cannot keep pace with the ATP demand. This phosphocreatine energy shuttle is one of the most important energy systems in the body for short-burst, high-intensity activities — including weightlifting, sprinting, jumping, and other activities that require a rapid burst of power but that are limited by the rate of ATP regeneration rather than by the availability of fuel.
The Creatine Kinase Reaction
The creatine kinase reaction (PCr + ADP + H+ <-> Cr + ATP) is one of the most important buffer reactions in cellular energetics — it maintains the ATP concentration at levels that are sufficient for the contractile machinery of the muscle when the ATP demand temporarily exceeds the rate of ATP production from glycolysis and oxidative phosphorylation. The CK reaction is spatially organised in the cell — the mitochondrial isozyme (mtCK) is located in the mitochondrial intermembrane space, where it is coupled to oxidative phosphorylation and continuously regenerates ATP from the PCr stores; the cytosolic isozyme (mmCK) is located near the myofibrils, where it regenerates ATP at the exact location where it is needed for contraction. This spatial organisation of the CK system is one of the most elegant examples of metabolic compartmentalisation in cellular energetics, and it allows the muscle to maintain a high and relatively constant ATP concentration even during very high-intensity contraction when the ATP demand is 10-20 times the resting rate.
The clinical importance of the phosphocreatine system is demonstrated by the genetic deficiency of GAMT (guanidinoacetate methyltransferase), which is the enzyme that synthesises creatine from guanidinoacetate. GAMT deficiency is a rare autosomal recessive disorder that is characterised by the absence of creatine and phosphocreatine in muscle and brain, and by a clinical syndrome that includes intellectual disability, seizures, movement disorders (dystonia, choreoathetosis), and severe muscle weakness. The treatment of GAMT deficiency involves creatine supplementation (at 300-500mg/kg body weight daily, which partially compensates for the inability to synthesise creatine endogenously) and dietary arginine restriction (which reduces the production of guanidinoacetate, the precursor of creatine). The dramatic response to creatine supplementation in GAMT deficiency is one of the most powerful demonstrations of the essential role of creatine in cellular energy metabolism.
Creatine Supplementation and Athletic Performance
Creatine supplementation is one of the most effective and most well-studied supplements for athletic performance — it has been shown in hundreds of RCTs to increase muscle phosphocreatine stores, to improve performance during high-intensity exercise (particularly during the repeated bouts of high-intensity exercise that characterise team sports and resistance training), and to increase muscle mass and strength when combined with resistance training. The standard creatine loading protocol is 20g daily for 5-7 days (divided into 4 doses), followed by a maintenance dose of 3-5g daily. The loading phase rapidly saturates the muscle creatine stores; the maintenance dose maintains these elevated stores; and after the loading phase, the muscle creatine content is elevated by approximately 20-30% above the pre-supplementation baseline. The performance benefits of this elevated muscle creatine are most apparent during the high-intensity exercise bouts that are limited by the rate of ATP regeneration — including weightlifting, sprinting, and the repeated high-intensity efforts that are characteristic of team sports.
Practical Application
For general creatine supplementation, the evidence-based approach is to use creatine monohydrate (which is the most extensively studied and the most cost-effective form) at 3-5g daily as a maintenance dose, with or without a loading phase of 20g daily for 5-7 days. Creatine monohydrate is the most evidence-based form of creatine for athletic performance and for the support of muscle function in older adults with sarcopenia. The only adverse effect that is consistently reported with creatine supplementation is weight gain (from the increased water content of muscle, which is approximately 1-2kg after the loading phase), and the occasional GI upset that can occur with large single doses. For comprehensive athletic performance support, creatine pairs well with the protein and amino acids (particularly the BCAAs, which support muscle protein synthesis; and beta-alanine, which increases muscle carnosine and buffers the muscle acidosis that accompanies high-intensity exercise), with caffeine (which combat central fatigue and which synergise with creatine for high-intensity performance), and with the progressive overload resistance training programme (which is the essential stimulus for muscle protein synthesis and for the conversion of the additional muscle creatine into functional muscle hypertrophy and strength).
Leave a Reply